SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
AMETEK entered into material financing agreements comprising a $3.5 billion amended revolving credit facility and a $4.0 billion term loan facility to fund the previously announced Indicor Acquisition. Up to $1.0 billion of revolving loan proceeds and the entire $4.0 billion term loan are designated for the acquisition consideration and related costs.
View raw filing on EDGAR →This exhibit is a press release announcing C21 Investments' audited financial statements and results for the fourth quarter and fiscal year ending March 31, 2026. The document discloses key financial metrics including revenue of $32.6 million (up 8.3%), gross margin of 42%, income from operations of $2.3 million (up 78%), and record customer transactions of 725,000 (up 16%). The company explicitly states it is announcing "the filing of its audited financial statements and management discussion and analysis" and provides detailed fiscal year and quarterly highlights with comparative prior-year data, which is characteristic of an earnings release rather than a periodic financial report itself.
View raw filing on EDGAR →Austin Gold has filed a National Instrument 43-101 technical report on its Stockade Mountain Project documenting exploration activities, drilling results (including significant gold grades of 8.19 g/t and 9.32 g/t), and identifying new untested drill targets based on geophysical surveys. This material operational disclosure advances the company's core business objective of making district-scale gold discoveries and demonstrates progress on its primary asset.
View raw filing on EDGAR →Dick's Sporting Goods held its 2026 annual meeting of stockholders on June 10, 2026, with voting results disclosed on four proposals: election of eleven directors, advisory approval of named executive officer compensation, ratification of Deloitte & Touche LLP as independent auditor, and a stockholder proposal on women's rights business risk reporting.
View raw filing on EDGAR →APPlife Digital Solutions Inc. effected a 1-for-250 reverse stock split approved by the Board on May 22, 2026, and effective June 12, 2026, which materially modifies the rights and economic interests of security holders by consolidating shares and adjusting warrant/option exercise prices. The reverse stock split was implemented through a Certificate of Amendment to the Articles of Incorporation, resulting in a new CUSIP number and temporary trading symbol change, with the stated purpose of improving marketability and liquidity.
View raw filing on EDGAR →JinkoSolar's board has declared a cash dividend of US$0.375 per ordinary share (US$1.50 per ADS), with a record date of June 22, 2026 and payment expected around July 9, 2026. The total distribution is approximately US$78.5 million. This is a straightforward dividend distribution announcement, a material capital return to shareholders that would affect investor assessment of the company's capital allocation and shareholder returns.
View raw filing on EDGAR →Noah Holdings declared a final dividend of RMB 0.933 per share for the year ended December 31, 2025, approved by shareholders on June 11, 2026, with ex-dividend date July 8, 2026 and payment date July 30, 2026.
View raw filing on EDGAR →Noah Holdings declared a special dividend of RMB 0.933 per share, approved by shareholders on June 11, 2026, with ex-dividend date July 8, 2026 and payment date July 30, 2026.
View raw filing on EDGAR →This exhibit discloses the poll results of the Annual General Meeting held on June 12, 2026, including voting outcomes on five resolutions: adoption of audited financial statements, re-election of directors, auditor re-appointment, share issuance/repurchase mandates, and articles of association amendments. All resolutions passed with overwhelming majorities (>99% in most cases), directly matching the shareholder_vote_results taxonomy definition.
View raw filing on EDGAR →Manchester United issued $550 million in 5.36% Senior Secured Notes due 2031 on June 10, 2026, creating a new direct financial obligation. The filing discloses the principal amount, interest rate, maturity date, security interests, and intended use of proceeds (prepayment of existing 2027 Notes and general corporate purposes). This is a material debt issuance under Item 2.03 equivalent disclosure.
View raw filing on EDGAR →Safehold formed a joint venture with a Brookfield affiliate involving contribution of ground lease assets generating $14 million in annualized cash rent, with Brookfield purchasing a 49% non-controlling interest at approximately $348 million gross valuation. This constitutes a material disposition/change of control event involving a significant portfolio of assets and substantial capital proceeds ($348 million) to be used for debt repayment and corporate purposes, fitting the ma_activity classification for entry into a material transaction.
View raw filing on EDGAR →Oddity Finance, a wholly-owned indirect subsidiary, entered into repurchase agreements on June 11, 2026 to repurchase $50 million in aggregate principal amount of 0% Exchangeable Senior Notes due 2030 for $35 million, with $550 million remaining outstanding. This is a material modification of the company's debt structure—a debt tender offer or repurchase that reduces outstanding obligations and affects the registrant's capital structure and financial position.
View raw filing on EDGAR →This is a press release announcing 51Talk's unaudited financial results for the first quarter ended March 31, 2026. The exhibit discloses net revenues of US$31.2 million (70.9% YoY increase), gross billings of US$33.3 million (51.9% YoY increase), active students of 132,900 (63.9% YoY increase), and a net loss of US$2.3 million. It includes full financial statements (balance sheet, income statement, and non-GAAP reconciliations) and forward guidance for Q2 2026. This is a discrete earnings announcement, not a periodic financial report filing.
View raw filing on EDGAR →United Community Banks divested two wholly owned subsidiaries—Navitas Credit Corp. and NLFC Reinsurance Corp.—to Navitas TopCo LLC pursuant to a Stock Purchase Agreement executed June 11, 2026, with an estimated base purchase price of approximately $1.9 billion, representing a significant change of control of material business units.
View raw filing on EDGAR →This exhibit is a Fourth Amending Agreement to an existing credit facility dated May 7, 2026. The document amends and extends the terms of Fortis Inc.'s revolving credit facility with a syndicate of major Canadian and international banks. While the amendment itself does not create new debt, it materially modifies the borrower's direct financial obligations by extending the maturity date and adjusting facility terms, which constitutes a modification of existing debt obligations. The extension fee of 3.5 basis points per annum and the involvement of multiple major lenders (Bank of Nova Scotia, RBC, CIBC, BMO, TD, etc.) indicate this is a material refinancing event affecting the company's capital structure.
View raw filing on EDGAR →Advanced Energy Industries announced a notice of redemption for $136.7 million of convertible senior notes due 2028, scheduled for September 23, 2026. While this is a material capital event affecting the company's debt structure and convertible security holders, it does not fit cleanly into the more specific event categories (not a restatement, auditor change, going concern, impairment, delisting, bankruptcy, covenant breach, or litigation). The redemption is a significant financial transaction that would affect investor assessment of the company's capital management and liquidity position.
View raw filing on EDGAR →The Company entered into an at-the-market (ATM) equity distribution agreement on June 12, 2026, authorizing the sale of up to $250 million in common stock through multiple sales agents. This is a classic dilutive issuance under Rule 415 that would materially affect existing shareholders through potential equity dilution and is a significant capital-raising event for the registrant.
View raw filing on EDGAR →This announcement discloses a grant of 737,054 RSUs to 302 employees under the Company's 2021 Plan on June 12, 2026. The disclosure details the vesting schedules, market prices, clawback mechanisms, and the Board's rationale for the grants as a compensation and retention mechanism. This is a material compensatory arrangement for employees that affects the Company's capital structure and incentive programs, consistent with Item 5.02(e) disclosure of executive and employee compensation arrangements.
View raw filing on EDGAR →Triple Flag's wholly owned subsidiary has entered into an agreement to acquire a gold stream on the Ravenswood Gold Mine for US$440 million upfront cash consideration. This is a material acquisition of a revenue-generating asset that will immediately add cash flow and gold exposure, with first deliveries commencing Q3 2026. The transaction is significant enough to warrant an increase in the company's 2030 production outlook from 140,000–150,000 GEOs to 150,000–160,000 GEOs, demonstrating materiality to investors' assessment of the registrant's future performance and asset base.
View raw filing on EDGAR →The filing discloses Graf Global Corp.'s entry into a Business Combination Agreement with BIG3 HoldCo LLC, announced via joint press release on June 12, 2026. This constitutes a material acquisition/change of control transaction requiring disclosure under Item 1.01 or 2.01, though disclosed here under Item 7.01 (Regulation FD Disclosure). The proposed business combination involving Graf, Big3, and PubCo (Halfcourt Holdco, Inc.) is explicitly identified as a material transaction requiring SEC registration and shareholder approval.
View raw filing on EDGAR →The Company's Board approved estimated net asset values (NAVs) per share for multiple share classes (K-I, K, A, and B shares) as of March 31, 2026, based on independent appraisals and valuation methodology, and announced these valuations via press release on June 12, 2026. This valuation disclosure is material to investors in the non-traded REIT as it reflects the estimated value of their holdings and informs pricing for secondary market transactions and FINRA compliance.
View raw filing on EDGAR →This disclosure describes the entry into multiple material definitive agreements in connection with the issuance and sale of $911 million in asset-backed notes by Porsche Innovative Lease Owner Trust 2026-1. The transaction involves a structured securitization with transfers of assets (Transaction SUBI Certificate) through multiple entities (PFLP → PAF → Issuing Entity) and the creation of an indenture governing the notes. While technically a securitization rather than a traditional M&A transaction, the aggregate principal amount, the complexity of the transaction structure, and the involvement of multiple definitive agreements constitute a material capital-raising and asset-transfer event that would affect a reasonable investor's assessment of the registrant's financial position and obligations.
View raw filing on EDGAR →This Item 5.07 discloses the results of Nuvectis Pharma's 2026 Annual Meeting held on June 11, 2026, including voting outcomes for the election of a Class I director (Ron Bentsur) and ratification of Kesselman & Kesselman as independent auditor. All proposals were approved. While the filing notes a minor correction to the share count in the proxy statement (27.7M stated vs. 26.6M actual), this does not affect vote validity or outcomes. The core disclosure is the shareholder vote results, which is material to investors as it confirms board composition and auditor selection.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of G-III's Annual Meeting of Stockholders held on June 11, 2026. The filing presents voting results for four proposals: election of eleven directors, advisory vote on named executive officer compensation, amendment to the 2023 Long-Term Incentive Plan to increase authorized shares, and ratification of Ernst & Young LLP as independent auditor. All proposals passed with substantial majorities. This is material as it documents stockholder approval of key governance and compensation matters.
View raw filing on EDGAR →A tornado and severe storm damaged Hudson Technologies' primary refrigerant reclamation facility in Champaign, Illinois on June 11, 2026, causing "extensive roof, structural and water damage" and forcing operational diversion to other facilities. While this is a material event affecting operations and requiring insurance recovery, it does not fit neatly into the more specific event categories (not a restatement, impairment charge, litigation, or cybersecurity incident). The disclosure indicates significant infrastructure damage and operational disruption that would affect investor assessment of the company's near-term performance and asset condition.
View raw filing on EDGAR →The filing discloses an unregistered issuance of 4,657,499 Class A ordinary shares to the Sponsor upon conversion of Class B shares, relying on Section 3(a)(9) exemption. While technically a conversion rather than a new issuance, this represents a material change in share structure and voting control—the Sponsor's converted shares now constitute approximately 21% of outstanding Class A shares (4.66M of 21.9M total). The event is material to investors assessing ownership concentration and governance, though the lack of cash proceeds and the pre-existing relationship with the Sponsor (as existing security holder) reduce the dilutive impact compared to a typical PIPE or private placement.
View raw filing on EDGAR →Century Therapeutics held its 2026 Annual Meeting of Stockholders on June 11, 2026, at which shareholders voted on and approved four proposals: election of Class II directors (Alessandro Riva and Han Lee), ratification of Ernst & Young LLP as independent auditor, approval of an amendment to the Certificate of Incorporation to increase authorized common shares from 300 million to 450 million, and approval of a potential meeting adjournment.
View raw filing on EDGAR →Soligenix received a written notice from Nasdaq on June 10, 2026, indicating noncompliance with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The company has 180 calendar days (until December 7, 2026) to regain compliance, with explicit warning that failure to do so will result in delisting notification.
View raw filing on EDGAR →The Company terminated its HyBryte™ development program following a Data Monitoring Committee recommendation of futility in the Phase 3 FLASH2 trial, with estimated wind-down costs of $70,000. This represents a material strategic decision to discontinue a clinical program affecting the Company's pipeline and strategic direction.
View raw filing on EDGAR →Tim Walbert, a Board member of Sagimet Biosciences Inc., tendered his resignation from the Board effective June 12, 2026, due to other commitments.
View raw filing on EDGAR →Sagimet Biosciences held its 2026 Annual Meeting of Stockholders on June 12, 2026, with shareholders voting to elect four Class III directors (Jennifer Jarrett, Anne Phillips, David Happel, and George Kemble) and ratify KPMG LLP as the independent registered public accountant.
View raw filing on EDGAR →Service Properties Trust held its Annual Meeting of shareholders and disclosed voting results on multiple matters, including election of seven Trustees, advisory vote on named executive officer compensation, ratification of Deloitte & Touche LLP as independent auditors, and approval of an amended and restated Share Award Plan increasing the share pool by 4,000,000 shares and extending the plan term to 2036.
View raw filing on EDGAR →This Item 5.07 filing discloses the final results of the Company's annual meeting of shareholders held on June 10, 2026, including the election of seven Trustees to the Board, a non-binding advisory vote on named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditors. The disclosure provides vote tallies (For, Against, Withhold, Abstain, Broker Non-Votes) for each matter, which is the core content of shareholder vote results disclosures.
View raw filing on EDGAR →Jami A. Statham, Senior Vice President, General Counsel and Corporate Secretary, notified the Company on June 10, 2026 of her intention to step down effective July 9, 2026. While the disclosure includes compensatory arrangement details (continued salary, benefits, equity vesting, and bonus), the principal disclosed action is the departure of a named executive officer from a senior legal and governance role. The departure is the salient event driving the filing.
View raw filing on EDGAR →The disclosure centers on the Board's appointment of Christiane Pendarvis as a new director, effective July 2, 2026, increasing the Board size from eight to nine members. While the section also mentions her eligibility for standard non-employee director compensation, the principal disclosed action is her appointment to the Board, making this an exec_appointment event. The appointment of a qualified independent director with significant retail and consumer business experience is material to investors' assessment of the company's governance.
View raw filing on EDGAR →This disclosure announces the commencement of separate trading of Class A Ordinary Shares and Warrants from the Company's IPO units, effective June 18, 2026. While this is a routine structural event for blank-check companies, it is material to investors as it affects the liquidity, trading mechanics, and investment options available for the securities issued in the IPO. The announcement specifies the new ticker symbols ("IACQ" and "IACQW") and the warrant exercise price ($11.50), which are substantive details affecting security holders' ability to trade and exercise their rights.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from the June 11, 2026 Annual Meeting of Stockholders. The filing reports the final vote tallies for the election of three Class I directors (Buckman, Johnson, MacDiarmid) and the ratification of UHY LLP as independent auditor, which are routine but material matters requiring Item 5.07 disclosure under SEC rules.
View raw filing on EDGAR →This Item 5.07 disclosure reports the voting results from Citi Trends' June 10, 2026 annual meeting of stockholders, including the election of eight directors, advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. The detailed vote tallies for each director nominee and proposal are presented in tabular form, which is the standard format for shareholder vote results disclosures.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from BKV Corporation's Annual Meeting of Stockholders held on June 11, 2026. The filing reports final voting tallies for two proposals: (1) election of four Class II director nominees (Akaraphong Dayananda, Thiti Mekavichai, Sunit S. Patel, and Carla Mashinski) and (2) ratification of PricewaterhouseCoopers LLP as independent auditor. Director elections and auditor ratifications are material governance matters that affect investor assessment of board composition and financial oversight.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting held on June 11, 2026. The filing reports the voting outcomes for two proposals: (1) election of four Class II directors with specific vote tallies for each nominee (Joseph J. DeAngelo, Brian F. Hughes, Mark R. James, and Thomas R. Knott), and (2) ratification of Ernst & Young LLP as independent auditor. All proposals passed. This is a quintessential Item 5.07 shareholder vote results disclosure.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of 908 Devices Inc.'s 2026 Annual Meeting of Stockholders held on June 11, 2026. The filing presents voting outcomes for four proposals: election of three Class III directors (Keith L. Crandell, Christopher Brown, Ph.D., and E. Kevin Hrusovsky), ratification of PricewaterhouseCoopers LLP as independent auditor, advisory vote on named executive officer compensation, and advisory vote on the frequency of future compensation votes. All proposals passed with substantial majorities. Shareholder vote results at annual meetings are material disclosures affecting investor understanding of corporate governance and board composition.
View raw filing on EDGAR →Jason Robins was appointed as Chief Financial Officer, effective June 10, 2026. The appointment represents a material change in the company's financial leadership.
View raw filing on EDGAR →The 2026 Annual Meeting of Stockholders approved the election of Class III directors (Pravin U. Dugel, M.D. and Merilee Raines), advisory votes on named executive officer compensation and voting frequency, Amendment No. 5 to the 2021 Stock Incentive Plan increasing authorized shares by 10,000,000, and ratification of PricewaterhouseCoopers LLP as independent auditor.
View raw filing on EDGAR →TopBuild entered into supplemental indentures amending its debt instruments in connection with the "previously announced acquisition of the Company pursuant to the Agreement and Plan of Merger, dated as of April 18, 2026, among the Company, QXO, Inc." The amendments eliminate change-of-control offer requirements and restrictive covenants to facilitate the merger with QXO. This is a material definitive agreement directly tied to the pending acquisition transaction, which is the core M&A activity being disclosed.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from Hut 8 Corp.'s June 11, 2026 Annual Meeting of Stockholders. The filing presents detailed voting tallies for four proposals: election of eight directors, advisory vote on named executive officer compensation, ratification of KPMG LLP as independent auditor, and approval of an amendment to the 2023 Omnibus Incentive Plan. All proposals passed with substantial majorities, and the disclosure is material as it documents the outcome of fundamental corporate governance matters.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Seaport Entertainment Group's 2026 annual meeting of stockholders held on June 8, 2026. The filing presents voting results for two proposals: election of five directors (Matthew M. Partridge, Michael A. Crawford, Monica S. Digilio, David Z. Hirsh, and Anthony F. Massaro) and ratification of Grant Thornton LLP as independent auditor. Both proposals passed. Director elections and auditor ratification are material governance matters affecting investor confidence in board composition and financial oversight.
View raw filing on EDGAR →Energous Corp held its Annual Meeting of Stockholders on June 11, 2026, with a 55.06% quorum. Stockholders approved three proposals: election of four directors (David Roberson, Mallorie Burak, J. Michael Dodson, and Rahul Patel), ratification of BPM LLP as independent auditor, and approval of the Amended and Restated 2024 Equity Incentive Plan.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Stagwell Inc.'s annual meeting of stockholders held on June 11, 2026. The filing presents voting results for three proposals: election of nine directors, advisory approval of executive compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. All three proposals passed with substantial majorities, making this a material shareholder vote results disclosure.
View raw filing on EDGAR →Universal Safety Products entered into a Securities Purchase Agreement to sell convertible promissory notes totaling up to $10.6 million principal to SJC Lending LLC under a Section 4(a)(2) private placement exemption. The conversion of these notes would result in issuance of shares exceeding 19.99% of outstanding common stock, requiring stockholder approval under NYSE American rules, representing a material dilutive equity issuance.
View raw filing on EDGAR →Adagio Medical received a notice from Nasdaq on June 12, 2026, that its common stock failed to comply with Nasdaq Listing Rule 5550(a)(2) due to a minimum bid price below $1.00 per share for 30 consecutive business days. The Company has 180 calendar days until December 9, 2026, to regain compliance, with a potential second 180-day period available if certain conditions are met. Failure to regain compliance will result in delisting notification. This is a material disclosure of delisting risk under Item 3.01.
View raw filing on EDGAR →